You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

antibody (Ab) response

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Vaccine Reaction Trial in Venice-Lido (blood sample collection)

Active, not recruiting
  • Vaccine Reaction
  • blood sample collection
  • Venice-Lido, Italy
    IRCCS San Camillo
Aug 24, 2022

Covid19 Trial in Örebro (L. reuteri DSM 17938 + vitamin D, Placebo + vitamin D)

Completed
  • Covid19
  • L. reuteri DSM 17938 + vitamin D
  • Placebo + vitamin D
  • Örebro, Örebro Län, Sweden
    Örebro University
Oct 14, 2021

Advanced Solid Tumors Trial in Canada, United States (LCB84, Anti-PD-1 mAb)

Not yet recruiting
  • Advanced Solid Tumors
  • LCB84
  • Anti-PD-1 monoclonal antibody
  • Los Angeles, California
  • +6 more
Jul 4, 2023

HIV Trial run by the National Institute of Allergy and Infectious Diseases (NIAID) (VRC-HIVMAB0115-00-AB)

Recruiting
  • HIV
  • VRC-HIVMAB0115-00-AB
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Feb 2, 2023

Leukemia Trial (90-Yttrium-labelled anti-CD66 mAb)

Not yet recruiting
  • Leukemia
  • 90-Yttrium-labelled anti-CD66 monoclonal antibody
  • (no location specified)
Aug 16, 2022

Profiling Spike Protein Antibody Response Post COVID Booster

Not yet recruiting
  • SARS-CoV-2 Booster
  • Spike Protein IgG Antibody
  • Obtain antibody titers
  • (no location specified)
Jul 25, 2022

Healthy Adult Immune Response Trial run by the NIAID (VRC-HIVMAB095-00-AB (10E8VLS), VRC-HIVMAB075-00-AB (VRC07-523LS))

Terminated
Has Results
  • Healthy Adult Immune Response
  • VRC-HIVMAB095-00-AB (10E8VLS)
  • VRC-HIVMAB075-00-AB (VRC07-523LS)
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Dec 8, 2020

Glioblastoma Trial in New Haven (AB122, AB154, Placebo)

Recruiting
  • Glioblastoma
  • New Haven, Connecticut
    Yale University
Jul 5, 2022

Standard Operating Procedures for Anti-HPV Antibody Detection in

Completed
  • Human Papilloma Virus Infection
  • First-void urine collection
  • Blood draw
  • Wilrijk, Antwerp, Belgium
    university of Antwerp - centre for the evaluation of vaccination
Nov 7, 2022

Paroxysmal Nocturnal Hemoglobinuria Treated With Anti-C5

Completed
  • Paroxysmal Nocturnal Hemoglobinuria
  • Anti-C5 antibody treatment
  • Paris, France
    AP-HP Hôpital Saint Louis
Apr 24, 2023

Plasmodium Falciparum Infection, Malaria Trial in Kalifabougou, Torodo (VRC-MALMAB0100-00-AB (CIS43LS), Normal saline)

Active, not recruiting
  • Plasmodium Falciparum Infection
  • Malaria
  • VRC-MALMAB0100-00-AB (CIS43LS)
  • Normal saline
  • Kalifabougou, Région De Koulikoro, Mali
  • +1 more
Sep 20, 2022

Chronic Liver Disease Trial in Hong Kong (BNT162b2, CoronaVac, AZD1222)

Recruiting
  • Chronic Liver Disease
  • BNT162b2
  • +2 more
  • Hong Kong, Hong Kong
    Humanity & Health Medical Group Limited
Aug 1, 2022

IsThird Dose of MMRV Vaccine Beneficial for Adult Population in

Not yet recruiting
  • Vaccination Failure
  • Vaccine Response Impaired
  • Serology for antibody levels - Baseline
  • +3 more
  • (no location specified)
Jun 26, 2023

Anti-CGRP Monoclonal Antibody Response After Switching (AMARAS)

Recruiting
  • Migraine
  • Head Pain
    • Valladolid, Spain
      Hospital Clínico Universitario de Valladolid
    Mar 23, 2023

    Atopic Dermatitis, Moderate-to-severe Atopic Dermatitis Trial in United States (Rocatinlimab, Placebo)

    Recruiting
    • Atopic Dermatitis
    • Moderate-to-severe Atopic Dermatitis
    • Canoga Park, California
    • +5 more
    Jun 15, 2023

    Respiratory Tract Infections Trial (Respiratory pathogen panel PCR test, COVID-19 antibody test)

    Not yet recruiting
    • Respiratory Tract Infections
    • Respiratory pathogen panel PCR test
    • COVID-19 antibody test
    • (no location specified)
    May 8, 2023

    HIV Antibodies Trial run by the NIAID (VRC-HIVMAB091-00-AB, EDP)

    Completed
    • HIV Antibodies
    • VRC-HIVMAB091-00-AB
    • EDP
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Oct 8, 2022

    HIV Trial in Switzerland, United States (VRC07-523LS, Placebo)

    Completed
    Has Results
    • HIV Infections
    • VRC07-523LS
    • Placebo
    • Birmingham, Alabama
    • +6 more
    Feb 21, 2022

    Melanoma (Skin) Trial in Tampa (MART-1, NY-ESO-1, gp100:209-217(210M))

    Completed
    • Melanoma (Skin)
    • MART-1
    • +5 more
    • Tampa, Florida
      H. Lee Moffitt Cancer Center and Research Institute
    Jan 17, 2023

    Antibody Response to COVID19 Vaccination in Multiple Sclerosis

    Completed
    • Multiple Sclerosis
    • Covid19
      • Livingston, New Jersey
        Saint Barnabas Medical Center
      Aug 16, 2022

      Borderline Resectable Pancreatic Adenocarcinoma, Locally Advanced Pancreatic Ductal Adenocarcinoma Trial in Los Angeles

      Not yet recruiting
      • Borderline Resectable Pancreatic Adenocarcinoma
      • Locally Advanced Pancreatic Ductal Adenocarcinoma
      • Biospecimen Collection
      • +9 more
      • Los Angeles, California
        Yonemoto,Lisa
      Jan 13, 2023

      Anti-SARS-CoV-2 Salivary Antibodies After COVID-19 Booster

      Terminated
      • Anti-SARS-CoV-2 Antibody Response
      • blood and saliva samples will be taken
      • Graz, Austria
        Medizinische Universität Graz, Klinische Abteilung für Rheumatol
      Jan 9, 2023

      COVID-19 IgG Antibodies in Maternal and Cord Blood Samples

      Withdrawn
      • Covid19
      • +2 more
        • (no location specified)
        Apr 19, 2022

        Monoclonal Antibody Duration of REsponse in MIgraine After

        Recruiting
        • Migraine
        • Headache, Migraine
        • Headache calendar completion
        • Valladolid, Spain
          Hospital Clínico Universitario de Valladolid
        Jul 15, 2022

        Nutrition Immunology Trial in Kannapolis (Cranberry, Placebo)

        Completed
        • Nutrition Immunology
        • Cranberry
        • Placebo
        • Kannapolis, North Carolina
          Appalachian State University Human Performance Lab, North Caroli
        Feb 18, 2022